Return-path: <azhar.anis@ferozsons-labs.com>
Envelope-to: sales_marketing@ferozsons-labs.com
Delivery-date: Fri, 26 Jul 2013 13:14:55 -0400
Received: from [119.157.135.12] (port=49312 helo=AzharAnisPC)
	by ecbiz132.inmotionhosting.com with esmtpa (Exim 4.80)
	(envelope-from <azhar.anis@ferozsons-labs.com>)
	id 1V2lbK-0007qx-8J; Fri, 26 Jul 2013 13:14:49 -0400
From: "Azhar Anis" <azhar.anis@ferozsons-labs.com>
To: "'Dr. Sohail Manzoor'" <sohail.manzoor@ferozsons-labs.com>,
	<sales_marketing@ferozsons-labs.com>,
	<waqar.siddiqui@ferozsons-labs.com>
References: <00ac01ce89ea$79f401b0$6ddc0510$@ferozsons-labs.com>
In-Reply-To: <00ac01ce89ea$79f401b0$6ddc0510$@ferozsons-labs.com>
Subject: RE: few questions ...need out of box suggestions 
Date: Fri, 26 Jul 2013 22:14:39 +0500
Message-ID: <000001ce8a23$9fc35470$df49fd50$@anis@ferozsons-labs.com>
MIME-Version: 1.0
Content-Type: multipart/related;
	boundary="----=_NextPart_000_0001_01CE8A4D.88995C70"
X-Mailer: Microsoft Office Outlook 12.0
Thread-Index: Ac6J6ciPtBrziAMgTMC+RWLdmRRGLAANZbHQ
Content-Language: en-us

This is a multi-part message in MIME format.

------=_NextPart_000_0001_01CE8A4D.88995C70
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_0002_01CE8A4D.88995C70"


------=_NextPart_001_0002_01CE8A4D.88995C70
Content-Type: text/plain;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

Respected Sir,

                        HOW TO INCREASE THE NUMBER OF PRESCRIBING DOCTOR'S

 

1.      They should be a focus on one product for one non prescriber at the
leave of each HCR and ASM in every qtr. After doing frequent visits and
strong follow up taking by the ZSM also, the non prescriber would definitely
be converted in to prescriber. In this way at the end of a qtr we could get
at least on new prescriber from each territory and if we have maximum eight
territories we can develop a pool of eight new prescriber 

2.      Hold fast the loyal prescribers by keep on doing ROIs regularly.

 

HOW TO IMPROVE PATIENTS DAILY DOSE

1.      Patients awareness program should be arranged in the doctor's clinic
in the at regular basis to educate the patients e.g. how to take medicine,
what are the benefits of taking regular dose etc. We can take the services
of CRA for this activity. 

2.      We can also give some incentive to the patients as well,  it they
are using medicine for at least three months, when they visit the doctor
with empty packs of that medicine company can offer free test for such
patients.

 

Regards

Description: Description: Description: C:\Documents and Settings\Nadeem
Afzal\Desktop\PICS for Slides\logo\1.png

M.Azhar Anis

ZSM (Cardiology ) South

C + 92 (332) 4180393

C + 92 (300) 2208237

P + 92(021) 34386852

E .  <mailto:azhar.anis@ferozsons-labs.com> azhar.anis@ferozsons-labs.com  

 

 

From: Dr. Sohail Manzoor [mailto:sohail.manzoor@ferozsons-labs.com] 
Sent: Friday, July 26, 2013 3:26 PM
To: sales_marketing@ferozsons-labs.com; waqar.siddiqui@ferozsons-labs.com
Subject: few questions ...need out of box suggestions 

 

Dear all

 

TWO questions ... need your INPUT 

 

Most sales persons win business from 10-15 drs....how to increase this
number of prescribing drs....

 

Patients do not take FULL DAILY DOSE and for the recommended DAYS  of
treatment ...how to IMPROVE this ...

 

Need some suggestions like TURING BENCH / tea cup saucer with tea bag place
/ chair with more utility 

 

Regards,

 

Dr. Sohail Manzoor

Commercial Director

Ferozsons Laboratories Limited.

5-KM, Sunder Raiwind Road,

Opp. Ijtima Chowk, Raiwind.

Lahore.

 

Tel: +92 42 32104001-3

Cell: +302 8229195

Email: sohail.manzoor@ferozsons-labs.com

 


------=_NextPart_001_0002_01CE8A4D.88995C70
Content-Type: text/html;
	charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" =
xmlns=3D"http://www.w3.org/TR/REC-html40"><head><meta =
http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dus-ascii"><meta name=3DGenerator content=3D"Microsoft Word 12 =
(filtered medium)"><!--[if !mso]><style>v\:* =
{behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Century Gothic";
	panose-1:2 11 5 2 2 2 2 2 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-priority:99;
	color:purple;
	text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-priority:99;
	mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:8.0pt;
	font-family:"Tahoma","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";}
span.EmailStyle17
	{mso-style-type:personal;
	font-family:"Calibri","sans-serif";
	color:windowtext;}
span.EmailStyle18
	{mso-style-type:personal-reply;
	color:black;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-priority:99;
	mso-style-link:"Balloon Text";
	font-family:"Tahoma","sans-serif";}
.MsoChpDefault
	{mso-style-type:export-only;
	font-size:10.0pt;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
/* List Definitions */
@list l0
	{mso-list-id:10837492;
	mso-list-type:hybrid;
	mso-list-template-ids:1444581848 67698703 67698713 67698715 67698703 =
67698713 67698715 67698703 67698713 67698715;}
@list l0:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l1
	{mso-list-id:444427083;
	mso-list-type:hybrid;
	mso-list-template-ids:-1175409530 67698703 67698713 67698715 67698703 =
67698713 67698715 67698703 67698713 67698715;}
@list l1:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.5in;
	text-indent:-.25in;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"2050" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]--></head><body lang=3DEN-US link=3Dblue =
vlink=3Dpurple><div class=3DWordSection1><p class=3DMsoNormal><span =
style=3D'font-family:"Century =
Gothic","sans-serif";color:#4F81BD'>Respected =
Sir,<o:p></o:p></span></p><p class=3DMsoNormal><span =
style=3D'font-family:"Century =
Gothic","sans-serif";color:#4F81BD'>&nbsp;&nbsp; =
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; HOW TO INCREASE THE =
NUMBER OF PRESCRIBING DOCTOR&#8217;S<o:p></o:p></span></p><p =
class=3DMsoNormal><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#4F81BD'><o:p>&nbsp;</o:p></span></p><p =
class=3DMsoListParagraph style=3D'text-indent:-.25in;mso-list:l0 level1 =
lfo1'><![if !supportLists]><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#4F81BD'><span =
style=3D'mso-list:Ignore'>1.<span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
</span></span></span><![endif]><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#4F81BD'>They should be a focus on one =
product for one non prescriber at the leave of each HCR and ASM in every =
qtr. After doing frequent visits and strong follow up taking by the ZSM =
also, the non prescriber would definitely be converted in to prescriber. =
In this way at the end of a qtr we could get at least on new prescriber =
from each territory and if we have maximum eight territories we can =
develop a pool of eight new prescriber <o:p></o:p></span></p><p =
class=3DMsoListParagraph style=3D'text-indent:-.25in;mso-list:l0 level1 =
lfo1'><![if !supportLists]><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#4F81BD'><span =
style=3D'mso-list:Ignore'>2.<span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
</span></span></span><![endif]><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#4F81BD'>Hold fast the loyal prescribers by =
keep on doing ROIs regularly.<o:p></o:p></span></p><p =
class=3DMsoListParagraph><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#4F81BD'><o:p>&nbsp;</o:p></span></p><p =
class=3DMsoListParagraph style=3D'margin-left:1.0in'><span =
style=3D'font-family:"Century Gothic","sans-serif";color:#4F81BD'>HOW TO =
IMPROVE PATIENTS DAILY DOSE<o:p></o:p></span></p><p =
class=3DMsoListParagraph =
style=3D'margin-left:1.5in;text-indent:-.25in;mso-list:l1 level1 =
lfo2'><![if !supportLists]><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#4F81BD'><span =
style=3D'mso-list:Ignore'>1.<span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
</span></span></span><![endif]><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#4F81BD'>Patients awareness program should be =
arranged in the doctor&#8217;s clinic in the at regular basis to educate =
the patients e.g. how to take medicine, what are the benefits of taking =
regular dose etc. We can take the services of CRA for this activity. =
<o:p></o:p></span></p><p class=3DMsoListParagraph =
style=3D'margin-left:1.5in;text-indent:-.25in;mso-list:l1 level1 =
lfo2'><![if !supportLists]><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#4F81BD'><span =
style=3D'mso-list:Ignore'>2.<span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
</span></span></span><![endif]><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#4F81BD'>We can also give some incentive to =
the patients as well,&nbsp; it they are using medicine for at least =
three months, when they visit the doctor with empty packs of that =
medicine company can offer free test for such =
patients.<o:p></o:p></span></p><p class=3DMsoNormal><span =
style=3D'color:black'><o:p>&nbsp;</o:p></span></p><p =
class=3DMsoNormal><i><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#00B0F0'> </span></i><b><i><span =
style=3D'font-family:"Century =
Gothic","sans-serif";color:black'>Regards<o:p></o:p></span></i></b></p><p=
 class=3DMsoNormal><span style=3D'color:black'><img width=3D146 =
height=3D29 id=3D"Picture_x0020_1" =
src=3D"cid:image001.png@01CE8A4D.84F66C20" alt=3D"Description: =
Description: Description: C:\Documents and Settings\Nadeem =
Afzal\Desktop\PICS for Slides\logo\1.png"></span><b><i><span =
style=3D'font-family:"Century =
Gothic","sans-serif";color:#D9D9D9'><o:p></o:p></span></i></b></p><p =
class=3DMsoNormal><b><i><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#D9D9D9'>M.Azhar =
Anis<o:p></o:p></span></i></b></p><p class=3DMsoNormal><b><i><span =
style=3D'font-family:"Century Gothic","sans-serif";color:#D9D9D9'>ZSM =
(Cardiology ) South<o:p></o:p></span></i></b></p><p =
class=3DMsoNormal><b><i><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#D9D9D9'>C + 92 (332) =
4180393<o:p></o:p></span></i></b></p><p class=3DMsoNormal><b><i><span =
style=3D'font-family:"Century Gothic","sans-serif";color:#D9D9D9'>C + 92 =
(300) 2208237<o:p></o:p></span></i></b></p><p =
class=3DMsoNormal><b><i><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#D9D9D9'>P + 92(021) =
34386852<o:p></o:p></span></i></b></p><p class=3DMsoNormal><b><i><span =
style=3D'font-family:"Century Gothic","sans-serif";color:#D9D9D9'>E . <a =
href=3D"mailto:azhar.anis@ferozsons-labs.com"><span =
style=3D'color:#D9D9D9'>azhar.anis@ferozsons-labs.com</span></a></span></=
i></b><span style=3D'font-family:"Century =
Gothic","sans-serif";color:#4F81BD'> &nbsp;<o:p></o:p></span></p><p =
class=3DMsoNormal><span =
style=3D'color:black'><o:p>&nbsp;</o:p></span></p><p =
class=3DMsoNormal><span =
style=3D'color:black'><o:p>&nbsp;</o:p></span></p><div><div =
style=3D'border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in =
0in 0in'><p class=3DMsoNormal><b><span =
style=3D'font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span>=
</b><span style=3D'font-size:10.0pt;font-family:"Tahoma","sans-serif"'> =
Dr. Sohail Manzoor [mailto:sohail.manzoor@ferozsons-labs.com] =
<br><b>Sent:</b> Friday, July 26, 2013 3:26 PM<br><b>To:</b> =
sales_marketing@ferozsons-labs.com; =
waqar.siddiqui@ferozsons-labs.com<br><b>Subject:</b> few questions =
...need out of box suggestions <o:p></o:p></span></p></div></div><p =
class=3DMsoNormal><o:p>&nbsp;</o:p></p><p class=3DMsoNormal>Dear =
all<o:p></o:p></p><p class=3DMsoNormal><o:p>&nbsp;</o:p></p><p =
class=3DMsoNormal>TWO questions &#8230;.. need your INPUT =
<o:p></o:p></p><p class=3DMsoNormal><o:p>&nbsp;</o:p></p><p =
class=3DMsoNormal>Most sales persons win business from 10-15 =
drs&#8230;&#8230;..how to increase this number of prescribing =
drs&#8230;&#8230;..<o:p></o:p></p><p =
class=3DMsoNormal><o:p>&nbsp;</o:p></p><p class=3DMsoNormal>Patients do =
not take FULL DAILY DOSE and for the recommended DAYS &nbsp;of treatment =
&#8230;..how to IMPROVE this &#8230;&#8230;&#8230;<o:p></o:p></p><p =
class=3DMsoNormal><o:p>&nbsp;</o:p></p><p class=3DMsoNormal>Need some =
suggestions like <b><span =
style=3D'font-size:14.0pt;color:#7030A0'>TURING BENCH / tea cup saucer =
with tea bag place / chair with more utility =
</span></b><o:p></o:p></p><p class=3DMsoNormal><o:p>&nbsp;</o:p></p><p =
class=3DMsoNormal>Regards,<o:p></o:p></p><p =
class=3DMsoNormal><o:p>&nbsp;</o:p></p><p class=3DMsoNormal>Dr. Sohail =
Manzoor<o:p></o:p></p><p class=3DMsoNormal>Commercial =
Director<o:p></o:p></p><p class=3DMsoNormal>Ferozsons Laboratories =
Limited.<o:p></o:p></p><p class=3DMsoNormal>5-KM, Sunder Raiwind =
Road,<o:p></o:p></p><p class=3DMsoNormal>Opp. Ijtima Chowk, =
Raiwind.<o:p></o:p></p><p class=3DMsoNormal>Lahore.<o:p></o:p></p><p =
class=3DMsoNormal><o:p>&nbsp;</o:p></p><p class=3DMsoNormal>Tel: +92 42 =
32104001-3<o:p></o:p></p><p class=3DMsoNormal>Cell: +302 =
8229195<o:p></o:p></p><p class=3DMsoNormal>Email: <a =
href=3D"mailto:sohail.manzoor@ferozsons-labs.com">sohail.manzoor@ferozson=
s-labs.com</a><o:p></o:p></p><p =
class=3DMsoNormal><o:p>&nbsp;</o:p></p></div></body></html>
------=_NextPart_001_0002_01CE8A4D.88995C70--

------=_NextPart_000_0001_01CE8A4D.88995C70
Content-Type: image/png;
	name="image001.png"
Content-Transfer-Encoding: base64
Content-ID: <image001.png@01CE8A4D.84F66C20>
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------=_NextPart_000_0001_01CE8A4D.88995C70--

